Bharat Parenterals Stock Price Analysis and Quick Research Report. Is Bharat Parenterals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bharat Parenterals. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bharat Parenterals has a PE ratio of 38.6484130297119 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bharat Parenterals has ROA of 6.5011% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bharat Parenterals has a Current ratio of 1.3003.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bharat Parenterals has a ROE of 11.181%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Bharat Parenterals has a Debt to Equity ratio of 0.3887 which means that the company has low proportion of debt in its capital.

• Sales growth: Bharat Parenterals has reported revenue growth of 16.5959% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Bharat Parenterals for the current financial year is 11.4786348931804%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bharat Parenterals is Rs 1 and the yield is 0.0735%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bharat Parenterals is Rs 35.2149. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bharat Parenterals in Ticker for free. Also, one can get the intrinsic value of Bharat Parenterals by using Valuation Calculators, which are available with a Finology ONE subscription. 

Bharat Parenterals FAQs

Q1. What is Bharat Parenterals share price today?
Ans: The current share price of Bharat Parenterals is Rs 1361.

Q2. What is the market capitalisation of Bharat Parenterals?
Ans: Bharat Parenterals has a market capitalisation of Rs 937.9961643 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Bharat Parenterals?
Ans: The PE ratio of Bharat Parenterals is 38.6484130297119 and the P/B ratio of Bharat Parenterals is 2.36377098063844, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Bharat Parenterals share?
Ans: The 52-week high share price of Bharat Parenterals is Rs 1870, and the 52-week low share price of Bharat Parenterals is Rs 802.

Q5. Does Bharat Parenterals pay dividends?
Ans: Currently, Bharat Parenterals pays dividends. Dividend yield of Bharat Parenterals is around 0.0735%.

Q6. What are the face value and book value of Bharat Parenterals shares?
Ans: The face value of Bharat Parenterals shares is Rs 10, while the book value per share of Bharat Parenterals is around Rs 575.7749. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Bharat Parenterals?
Ans: Bharat Parenterals has a total debt of Rs 83.0224 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Bharat Parenterals?
Ans: The ROE of Bharat Parenterals is 11.181% and ROCE of Bharat Parenterals is 13.0228%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Bharat Parenterals a good buy for the long term?
Ans: The Bharat Parenterals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Bharat Parenterals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Bharat Parenterals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Bharat Parenterals’s financials?
Ans: You can review Bharat Parenterals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.